Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
Noosa News21 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News16 hours agoHelp to make recycling stick
-
Noosa News14 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business16 hours agoAlphabet’s stock looks like a brilliant buy right now